Journey Medical Share Price (NASDAQ: DERM)

$7.22

▲

-0.05

(-0.69%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Journey Medical Stock chart to analyse performance

Journey Medical stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$7.09
Today's High:$7.22
$7.22
1.8%
Downside
Day's Volatility :1.8%
Upside
0.0%
52 Weeks Low:$3.54
52 Weeks High:$8.90
$7.22
51.04%
Downside
52 Weeks Volatility :60.28%
Upside
18.88%

Journey Medical Stock Returns

Period	Journey Medical Corp	Index (Russel 2000)
3 Months	-8.71%	0.0%
6 Months	41.19%	0.0%
1 Year	48.85%	0.0%
3 Years	122.46%	-4.7%

Journey Medical Corp Key Stats

Check Journey Medical key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$7.27
Open	$7.19
Today's High	$7.22
Today's Low	$7.09
Market Capitalization	$177.2M
Today's Volume	$132.1K
52 Week High	$8.8999
52 Week Low	$3.535
Revenue TTM	$56.4M
EBITDA	$-2.9M
Earnings Per Share (EPS)	$-0.37
Profit Margin	-15.49%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-57.22%

Stock Returns calculator for Journey Medical Stock including INR - Dollar returns

The Journey Medical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Journey Medical investment value today

Current value as on today

₹1,50,264

Returns

₹50,264

(+50.26%)

Returns from Journey Medical Stock

₹44,980 (+44.98%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Journey Medical Stock

150%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Journey Medical Stock from India on INDmoney has increased by 150% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Journey Medical Corp

Name
Holdings %
Name
Holdings %
TANG CAPITAL MANAGEMENT LLC
7.90%
Wasatch Advisors LP
4.91%
Vanguard Group Inc
2.41%
Renaissance Technologies Corp
1.01%
Essex Investment Management Company, LLC
0.97%
American Financial Group Inc
0.77%

Analyst Recommendation on Journey Medical Stock

Rating

Trend

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Journey Medical(by analysts ranked 0 to 5 stars)

Journey Medical Share Price Target

What analysts predicted

Upside of 63.43%

Target:

$11.80

Current:

$7.22

Journey Medical share price target is $11.80, a slight Upside of 63.43% compared to current price of $7.22 as per analysts' prediction.

Journey Medical Stock Insights

Price Movement
In the last 7 days, DERM stock has moved down by -4.6%
Increasing Revenue
Revenue is up for the last 2 quarters, 13.13M → 15.00M (in $), with an average increase of 12.5% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -4.07M → -3.79M (in $), with an average increase of 7.3% per quarter

Journey Medical Corp Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$34.9M	↓ 17.52%
Net Income	$3.6M	↓ 101.64%
Net Profit Margin	10.38%	↑ 533.63%

	FY20	Y/Y Change
Revenue	$44.5M	↑ 27.52%
Net Income	$5.3M	↑ 45.74%
Net Profit Margin	11.86%	↑ 1.48%

	FY21	Y/Y Change
Revenue	$63.1M	↑ 41.78%
Net Income	$-44.0M	↓ 932.75%
Net Profit Margin	-69.68%	↓ 81.54%

	FY22	Y/Y Change
Revenue	$73.7M	↑ 16.69%
Net Income	$-29.6M	↓ 32.65%
Net Profit Margin	-40.22%	↑ 29.46%

	FY23	Y/Y Change
Revenue	$79.2M	↑ 7.48%
Net Income	$-3.9M	↓ 87.0%
Net Profit Margin	-4.87%	↑ 35.35%

	FY24	Y/Y Change
Revenue	$56.1M	↓ 29.11%
Net Income	$-14.7M	↑ 280.79%
Net Profit Margin	-26.14%	↓ 21.27%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$13.0M	↓ 14.6%
Net Income	$-10.4M	↑ 387.26%
Net Profit Margin	-80.14%	↓ 66.09%

	Q2 FY24	Q/Q Change
Revenue	$14.9M	↑ 14.01%
Net Income	$-3.4M	↓ 67.81%
Net Profit Margin	-22.63%	↑ 57.51%

	Q3 FY24	Q/Q Change
Revenue	$14.6M	↓ 1.52%
Net Income	$-2.4M	↓ 28.89%
Net Profit Margin	-16.34%	↑ 6.29%

	Q4 FY24	Q/Q Change
Revenue	$13.6M	↓ 6.9%
Net Income	$1.5M	↓ 163.64%
Net Profit Margin	11.17%	↑ 27.51%

	Q1 FY25	Q/Q Change
Revenue	$13.1M	↓ 3.53%
Net Income	$-4.1M	↓ 367.78%
Net Profit Margin	-31.0%	↓ 42.17%

	Q2 FY25	Q/Q Change
Revenue	$15.0M	↑ 14.23%
Net Income	$-3.8M	↓ 6.8%
Net Profit Margin	-25.29%	↑ 5.71%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$24.4M	↓ 40.75%

	FY20	Y/Y Change
Profit	$29.9M	↑ 22.75%

	FY21	Y/Y Change
Profit	$31.1M	↑ 3.72%

	FY22	Y/Y Change
Profit	$42.9M	↑ 38.14%

	FY23	Y/Y Change
Profit	$52.5M	↑ 22.44%

	FY24	Y/Y Change
Profit	$35.3M	↓ 32.87%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$6.2M	↓ 32.76%

	Q2 FY24	Q/Q Change
Profit	$8.3M	↑ 33.79%

	Q3 FY24	Q/Q Change
Profit	$9.3M	↑ 12.39%

	Q4 FY24	Q/Q Change
Profit	$11.4M	↑ 21.82%

	Q1 FY25	Q/Q Change
Profit	$8.3M	↓ 26.65%

	Q2 FY25	Q/Q Change
Profit	$9.0M	↑ 7.87%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$9.0M	↓ 104.23%
Investing Cash Flow	$-2.4M	↓ 81.86%
Financing Cash Flow	$-3.6M	↓ 110.04%

	FY20	Y/Y Change
Operating Cash Flow	$5.1M	↓ 43.09%
Investing Cash Flow	$-1.2M	↓ 50.0%
Financing Cash Flow	$-487.0K	↓ 86.29%

	FY21	Y/Y Change
Operating Cash Flow	$-2.2M	↓ 142.5%
Investing Cash Flow	$-10.0M	↑ 733.33%
Financing Cash Flow	$53.0M	↓ 10986.24%

	FY22	Y/Y Change
Operating Cash Flow	$-13.5M	↑ 520.54%
Investing Cash Flow	$-20.0M	↑ 100.0%
Financing Cash Flow	$16.5M	↓ 68.96%

	FY23	Y/Y Change
Operating Cash Flow	$5.2M	↓ 138.72%
Investing Cash Flow	$-5.0M	↓ 75.0%
Financing Cash Flow	$-4.8M	↓ 129.19%

	FY24	Y/Y Change
Operating Cash Flow	$-9.1M	↓ 274.18%
Investing Cash Flow	$-15.0M	↑ 200.0%
Financing Cash Flow	$17.0M	↓ 453.73%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$2.2M	↓ 292.31%
Investing Cash Flow	$-15.0M	-
Financing Cash Flow	$10.6M	↓ 3711.9%

Journey Medical Technicals Summary

Sell

Neutral

Buy

Journey Medical is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Journey Medical Corp Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Journey Medical Corp	-2.99%	41.19%	48.85%	122.46%	-24.95%
Haleon Plc Spon Ads	1.5%	-7.33%	-3.49%	69.05%	32.32%
United Therapeutics Corporation	3.57%	-1.69%	-13.51%	34.83%	71.41%
Zoetis Inc.	6.13%	-8.28%	-14.8%	-1.88%	-3.48%
Neurocrine Biosciences Inc.	8.29%	21.94%	11.59%	32.16%	20.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Journey Medical Corp	39.08	NA	NA	-0.32	-0.57	-0.06	NA	0.82
Haleon Plc Spon Ads	21.53	21.53	3.14	0.49	0.09	0.05	0.01	1.77
United Therapeutics Corporation	11.9	11.9	1.43	26.59	0.19	0.13	NA	158.65
Zoetis Inc.	26.97	26.97	2.53	6.33	0.53	0.15	0.01	11.21
Neurocrine Biosciences Inc.	41.3	41.3	0.27	6.74	0.13	0.09	NA	27.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Journey Medical Corp	Buy	$177.2M	-24.95%	39.08	-15.49%
Haleon Plc Spon Ads	Buy	$43.4B	32.32%	21.53	13.81%
United Therapeutics Corporation	Buy	$13.8B	71.41%	11.9	40.36%
Zoetis Inc.	Buy	$69.3B	-3.48%	26.97	27.83%
Neurocrine Biosciences Inc.	Buy	$13.8B	20.59%	41.3	13.88%

About Journey Medical Corp

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Emrosi for the treatment of inflammatory lesions of rosacea, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Organization	Journey Medical
Employees	41
CEO	Mr. Claude Maraoui
Industry	Health Technology

Key Management of Journey Medical Corp

Name	Title
Dr. Lindsay Allan Rosenwald M.D.	Executive Chairman
Mr. Claude Maraoui	Founder, President, CEO & Director
Mr. Joseph M. Benesch	CFO & Corporate Controller
Mr. Ramsey Alloush	COO, General Counsel & Company Secretary
Mr. Robert Nevin	Chief Commercial Officer
Jaclyn Jaffe	Senior Director of Corporate Operations
Mr. Louis Donati	Director of Market Access

Important FAQs about investing in DERM Stock from India :

What is Journey Medical share price today?

Journey Medical share price today is $7.22 as on August 30, 2025 at 1:29 am IST at the close of the market. Journey Medical share today touched a day high of $7.22 and a low of $7.09.

What is the 52 week high and 52 week low for Journey Medical share?

Journey Medical share touched a 52 week high of $8.90 and a 52 week low of $3.54. Journey Medical stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $7.22, lower by 18.88% versus the 52 week high.

How to invest in Journey Medical Stock (DERM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Journey Medical on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Journey Medical Shares that will get you 0.2078 shares as per Journey Medical share price of $7.22 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Journey Medical Stock (DERM) from India?

Indian investors can start investing in Journey Medical (DERM) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Journey Medical stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Journey Medical share’s latest price of $7.22 as on August 30, 2025 at 1:29 am IST, you will get 1.3850 shares of Journey Medical. Learn more about fractional shares .

What are the returns that Journey Medical has given to Indian investors in the last 5 years?

Journey Medical stock has given -24.95% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?